Antibodies have transformed life sciences and many other scientific disciplines by allowing detection, quantification and capture of molecular targets that otherwise would remain unfathomable. Antibodies have become indispensable for state of the art research and represent an invaluable experimental tool. Yet, antibodies are also at the nexus of reproducibility issues plaguing modern life sciences. With an estimated total of 4.5 million commercial antibodies from 350+ suppliers available, it can be a daunting task to choose an antibody used in various immunological assays e.g. ELISA, Western Blot, conjugated primary antibodies for Flow cytometry, Immunofluorescence and Immunohistochemistry.